These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31399283)

  • 21. A case of possible chemical leukoderma secondary to usage of skin whitening agents.
    Cho M; Otsuka A; Irie H; Kataoka T; Kabashima K
    Eur J Dermatol; 2018 Oct; 28(5):701-702. PubMed ID: 30355541
    [No Abstract]   [Full Text] [Related]  

  • 22. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
    Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
    Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disfiguring Leukoderma Caused by Banned Cosmetics: A Quiz.
    Atzori L; Zanniello R; Sarais G; Piras V; Pilloni L; Zucca M; Brundu MA; Rongioletti F
    Acta Derm Venereol; 2018 Oct; 98(9):914-915. PubMed ID: 29944166
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemical leukoderma due to hydroquinone: An unusual phenomenon.
    Das A; Ghosh A; Kumar P
    Indian J Dermatol Venereol Leprol; 2019; 85(5):567. PubMed ID: 30117459
    [No Abstract]   [Full Text] [Related]  

  • 25. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    Skin Res Technol; 2018 May; 24(2):175-179. PubMed ID: 29057565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical Mechanism of Rhododendrol-Induced Leukoderma.
    Ito S; Wakamatsu K
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439519
    [No Abstract]   [Full Text] [Related]  

  • 27. Apoptosis of melanocytes in vitiligo results from antibody penetration.
    Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
    J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of serum autoantibodies against premelanosome protein 17 increases in the vitiligo patients].
    Hu L; Sun L; Li Y; Li H; Liang D; Sun J; Wang X; Hu J; Xie X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):411-3, 417. PubMed ID: 23643172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.
    Kemp EH; Waterman EA; Hawes BE; O'Neill K; Gottumukkala RV; Gawkrodger DJ; Weetman AP; Watson PF
    J Clin Invest; 2002 Apr; 109(7):923-30. PubMed ID: 11927619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological basis of melanoma-associated vitiligo-like depigmentation.
    González R; Torres-López E
    Actas Dermosifiliogr; 2014 Mar; 105(2):122-7. PubMed ID: 23146137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel three dimensional imaging method for the measurement of area in vitiligo and chemical leukoderma.
    Hayashi M; Okamura K; Araki Y; Suzuki M; Tanaka T; Abe Y; Nakano S; Yoshizawa J; Hozumi Y; Inoie M; Suzuki T
    J Dermatol Sci; 2016 Nov; 84(2):219-221. PubMed ID: 27576766
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
    Zhu MC; Liu CG; Wang DX; Zhan Z
    Genet Mol Res; 2015 Dec; 14(4):16060-73. PubMed ID: 26662399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study.
    Ingordo V; Cazzaniga S; Raone B; Digiuseppe MD; Musumeci ML; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Battarra VC; Sirna R; Patrizi A; Naldi L
    Dermatology; 2014; 228(3):240-9. PubMed ID: 24603479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo.
    Hayashi M; Okamura K; Abe Y; Hozumi Y; Suzuki T
    J Dermatol; 2019 Jun; 46(6):548-550. PubMed ID: 30969438
    [No Abstract]   [Full Text] [Related]  

  • 35. The antibody response against MART-1 differs in patients with melanoma-associated leucoderma and vitiligo.
    Teulings HE; Willemsen KJ; Glykofridis I; Krebbers G; Komen L; Kroon MW; Kemp EH; Wolkerstorfer A; van der Veen JP; Luiten RM; Tjin EP
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1086-96. PubMed ID: 25043574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of skin-lightening products among selected urban communities in Accra, Ghana.
    Lartey M; Krampa FD; Abdul-Rahman M; Quarcoo NL; Yamson P; Hagan PG; Tettey Y; Gyasi R; Adjei AA
    Int J Dermatol; 2017 Jan; 56(1):32-39. PubMed ID: 27943305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroquinone-induced depigmentation: case report and review of the literature.
    Jow T; Hantash BM
    Dermatitis; 2014; 25(1):e1-5. PubMed ID: 24407054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
    Nishimaki-Mogami T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1.
    Waterman EA; Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
    Clin Exp Immunol; 2002 Sep; 129(3):527-32. PubMed ID: 12197895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is celiac disease common in patients with vitiligo?
    Seyhan M; Kandi B; Akbulut H; Selımoğlu MA; Karincaoğlu M
    Turk J Gastroenterol; 2011 Feb; 22(1):105-6. PubMed ID: 21480124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.